You are here

340B

AstraZeneca, Sanofi, Eli Lilly sue HHS over 340B opinion

AstraZeneca, Sanofi, Eli Lilly sue HHS over 340B opinion

Beckers Hospital Review

Flag link:

Feds tell pharma companies to pony up 340B discounts, but it's unclear whether they will

Feds tell pharma companies to pony up 340B discounts, but it's unclear whether they will

Fierce Pharma

Flag link:

Novo Nordisk to end 340B discounts on drugs dispensed at community pharmacies

Novo Nordisk to end 340B discounts on drugs dispensed at community pharmacies

Beckers Hospital Review

Flag link:

Novartis adds new restriction to 340B discount policy

Novartis adds new restriction to 340B discount policy

Beckers Hospital Review

Flag link:

HHS general counsel scolds Eli Lilly for halting 340B drug discounts

HHS general counsel scolds Eli Lilly for halting 340B drug discounts

Beckers Hospital Review

Flag link:

AHA to HHS: Stop drugmakers' 'abusive tactics' over 340B discounts

AHA to HHS: Stop drugmakers' 'abusive tactics' over 340B discounts

Beckers Hospital Review

Flag link:

Eli Lilly stops giving 340B discounts to contract pharmacies

Eli Lilly stops giving 340B discounts to contract pharmacies

Beckers Hospital Review

contract pharmacies

Flag link:

AstraZeneca slammed by advocacy group over drug discount denials

AstraZeneca slammed by advocacy group over drug discount denials

Beckers Hospital Review

Flag link:

Trump’s Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications

Trump’s Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications

Drug Channels

Flag link:

PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program

PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program

Drug Channels

specialty pharmacies

Flag link:

Here’s How PBMs and Specialty Pharmacies Snag Super-Size Profits from the 340B Program

Here’s How PBMs and Specialty Pharmacies Snag Super-Size Profits from the 340B Program

Drug Channels

specialty pharmacies

Flag link:

JAMA: Withdraw This Flawed and Inaccurate Article About the 340B Program and Drug Prices

JAMA: Withdraw This Flawed and Inaccurate Article About the 340B Program and Drug Prices

Drug Channels

Flag link:

New 340B Health Reports Confirms the Program’s Size—But Double-Dips on Hospitals’ Community Benefit Obligations

New 340B Health Reports Confirms the Program’s Size—But Double-Dips on Hospitals’ Community Benefit Obligations

Drug Channels

Flag link:

Federal Court Punts Regarding Remedy Related to CMS’ Invalidated Rule Concerning Medicare Hospital Outpatient Payment Rates for 340B Drugs

Federal Court Punts Regarding Remedy Related to CMS’ Invalidated Rule Concerning Medicare Hospital Outpatient Payment Rates for 340B Drugs

FDA Law Blog

Flag link:

EXCLUSIVE: 340B Program Purchases Reach $24.3 Billion—7%+ of the Pharma Market—As Hospitals’ Charity Care Flatlines

EXCLUSIVE: 340B Program Purchases Reach $24.3 Billion—7%+ of the Pharma Market—As Hospitals’ Charity Care Flatlines

Drug Channels

Flag link:

340B hospital program leads to higher costs, PhRMA says

340B hospital program leads to higher costs, PhRMA says

Healthcare Dive

Flag link:

Court rejects 340B payment cuts in big win for hospitals

Court rejects 340B payment cuts in big win for hospitals

Healthcare Dive

outpatient drugs

Flag link:

New analysis finds 340B medicine sales hit record high in 2017 and continue to grow as a share of total drug spending

New analysis finds 340B medicine sales hit record high in 2017 and continue to grow as a share of total drug spending

PhRMA

Flag link:

Specialty Pharmacies and PBMs Penetrate the 340B Program—And How Manufacturers Should Respond

Specialty Pharmacies and PBMs Penetrate the 340B Program—And How Manufacturers Should Respond

Drug Channels

specialty pharmacies

Flag link:

Our Exclusive Analysis: Nearly One in Three U.S. Pharmacies Is a 340B Contract Pharmacy; Five Chains Dominate

Our Exclusive Analysis: Nearly One in Three U.S. Pharmacies Is a 340B Contract Pharmacy; Five Chains Dominate

Drug Channels

Flag link:

Pages